See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: June 13, 2005

Healthy Patient Studies Renal Artery Disease Cancer Prevention

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Healthy Patient Studies

Male and female patients with low left ventricular ejection fraction will be recruited to determine if Warfarin (with target INR of 2.75 + 0.25) is superior to aspirin (325 mg per day) in the prevention of all-cause mortality and stroke. Eligible participants must be 18 or older, must be taking ACE-inhibitor medications; if intolerant, must be on a study-approved medication regimen and must be willing to have monthly blood testing. Research site located in Worcester, Mass.

More Information

Please see http://www.centerwatch.com/patient/studies/phasei.html.

-----

Renal Artery Disease

Comparison study of calcium acetate + atorvastatin and sevelamer +/- atorvastatin on cardiovascular calcification and phosphorus levels in patients with end-stage renal disease. Research site located in Hollywood, Fla.

More Information

Please see http://www.centerwatch.com/patient/studies/cat131.html.

-----

Cancer Prevention

Women at high risk for breast cancer are eligible for participation in this research study. Since breast cancer arises in the breast milk duct lining, this study will obtain breast duct cells from each participant using the technique of ductal lavage every six months for three years. Participants must be between ages 35-70, with intact nipples, have had a family history of breast cancer, and be available for five years. Research site located in Milwaukee, Wisc.

More Information

Please see http://www.centerwatch.com/patient/studies/cat580.html.

-----

Copyright 2005 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.